Discover how the free Kin Health app uses its $9M seed funding to translate medical jargon into clear appointment summaries.
Millions of breast cancer patients could be spared chemotherapy with a revolutionary new genomic test, a clinical trial has shown. The most common type of cancer in women in the UK, breast cancer is ...
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...
THE STATE’S FIRST MEDICAL MARIJUANA DISPENSARY, MARKING ANOTHER MILESTONE IN GETTING PRODUCTS FROM THE GROUND TO THE HANDS OF ...
Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without ...
A digital monitoring system for advanced cirrhosis may help detect deterioration earlier and reduce hospital admissions.
By Sahil Pandey and Sriparna Roy May 29 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of MannKind's inhaled rapid-acting insulin in children with diabetes, offering ...
Lucia Adarve spent nearly two decades trying to solve her condition ...
Taisie Seigrist, a 15-year-old track and cross-country athlete in Oklahoma, was diagnosed with Type 1 diabetes five years ago ...
Morning Overview on MSN
A daraxonrasib trial just held pancreatic cancer in check for 8.5 months in most patients — twice as long as standard chemo for tumors that spread after first-line treatment
Pancreatic cancer is the third-leading cause of cancer death in the United States, and for patients whose tumors spread after initial chemotherapy, the prognosis is brutal: standard second-line ...
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients with the condition who were treated with the cell therapy ...
In the race to forge the next Keytruda from PD-(L)1xVEGF bispecific antibodies, Pfizer and the BioNTech-Bristol Myers Squibb alliance are split on how to position overall survival—the gold-standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results